MAPK/ERK activation is associated with angiogenic growth factor signaling in tumor cells, suggesting that PDLIM2 may act as an oncogenic protein that promotes tumor formation and metastasis by activating MAPK/ERK [10]. Here, PDLIM2 is linked to neoplasm.